Research & Development
The Company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. ManiKaustubh Pharma is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes.
The R&D Center provides a nurturing environment to a multi-disciplinary team of scientists striving for excellence.
The Centre meets cGLP requirements, and is focused on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies and drug delivery systems.
The instrumentation and analytical knowledge base at the Centre facilitate:
- Complete impurity profiling in all products developed.
- Development of analytical methods and specifications from raw materials, to non-compendial finished products.
- In-house synthesis of reagents for analysing organolithiums and noble metals.
- Accelerated and real-time stability studies.
This reflects the Company’s commitment towards developing innovative technologies and creating a knowledge base in chemical synthesis, high quality generic formulations and development of drug delivery systems.
Our Process
We combine science and innovation to deliver better healthcare solutions
Clinical Development
Focused on developing effective formulations with proven safety and consistent therapeutic outcomes.
Regulatory & Access
Ensuring all products meet required regulatory standards and quality guidelines for safe distribution.
Biotech
Continuously improving formulations and exploring new combinations to enhance treatment effectiveness.
Functional Service
Strict quality control processes to maintain consistency, safety, and reliability in every product.
